Cormorant Asset Management, LP's Form 4 filing
Immuneering Corp (IMRX) · filed Apr 3, 2024
- Accession no.
- 0000929638-24-001336
- Filed
- Apr 3, 2024, 5:37 PM ET
- Trade date
- Apr 1, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 8 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.16M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cormorant Asset Management, LPCIK 0001583977 | 10% Owner |
| Chen BihuaCIK 0001599214 | 10% Owner |
| Cormorant Global Healthcare Master Fund, LPCIK 0001618442 | 10% Owner |
| Cormorant Private Healthcare Fund III LPCIK 0001817320 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2024 | Class A Common Stock | SSaleDisposed | −100 | $3.07 | −$307 | 3,295,173 | Indirect | |
| Apr 1, 2024 | Class A Common Stock | SSaleDisposed | −300 | $3.07 | −$919.5 | 3,294,873 | Indirect | |
| Apr 1, 2024 | Class A Common Stock | SSaleDisposed | −100 | $3.05 | −$305 | 3,294,773 | Indirect | |
| Apr 1, 2024 | Class A Common Stock | SSaleDisposed | −600 | $3.03 | −$1,818 | 3,294,173 | Indirect | |
| Apr 1, 2024 | Class A Common Stock | SSaleDisposed | −10 | $3.01 | −$30.1 | 3,294,163 | Indirect | |
| Apr 1, 2024 | Class A Common Stock | SSaleDisposed | −10 | $2.98 | −$29.8 | 3,294,153 | Indirect | |
| Apr 1, 2024 | Class A Common Stock | SSaleDisposed | −280 | $2.97 | −$831.6 | 3,293,873 | Indirect | |
| Apr 1, 2024 | Class A Common Stock | SSaleDisposed | −398,600 | $2.90 | −$1,155,940 | 2,895,273 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.